Abstract
Purpose
Studies have shown that postoperative serum C-reactive protein (CRP) measurement may be useful in predicting the type of complication, infective or otherwise, following surgery for colorectal cancer. It may be that the magnitude of the postoperative CRP is also associated with the severity of the complication. The aim of the present study was to examine the relationship between daily postoperative CRP concentrations and Clavien-Dindo complication grade.
Patients and methods
Data was recorded prospectively for patients undergoing elective, potentially curative, surgery for colorectal cancer in two hospitals between January 2011 and January 2013, n = 241. All patients had daily CRP measurement following surgery for the first four postoperative days. Complications were retrospectively classified by Clavien-Dindo grade.
Results
Of the 241 patients, the majority were male (59 %) and were over 65 years old (69 %). The majority had colonic (86 %) and node negative (65 %) disease. One hundred nineteen patients (49 %) developed a complication, and 28 (12 %) of these were Clavien-Dindo grade 3, 4 or 5. Median and established threshold CRP concentrations on postoperative days 2 (>190 mg/L), 3 (>170 mg/L) and 4 (>125 mg/L) were directly associated with an increase in the Clavien-Dindo grade (all p < 0.001).
Conclusion
There was a direct association between exceeding established postoperative day 2, 3 and 4 CRP thresholds and the severity of complications defined by the Clavien-Dindo grade.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Colorectal cancer is the fourth most common cancer in the UK [1]. Although long-term outcome is mostly related to stage at initial presentation, studies have shown that postoperative complications, and in particular anastomotic leak, have a negative impact on both short- and long-term survival [2].
There have been two recent meta-analyses (Warschkow et al. 2012, Singh et al. 2014) including more than 2000 patients which have shown the utility of postoperative serum CRP measurement in the early diagnosis of postoperative infective complications and anastomotic leak after colorectal surgery [3, 4]. The thresholds for CRP on postoperative days 2, 3 and 4 of approximately 190 mg/L, 170 mg/L and 125 mg/L, respectively, have been consistently reported to predict the development of infective complications. Serum albumin has also been investigated, and a concentration below 25 g/L on postoperative day 3 has been reported to be associated with the development of infective complications after surgery for colorectal cancer [5].
An alternative approach is to classify the severity of the complication based upon the intervention required to treat it [6]. A recent retrospective study (Selby et al. 2014) with a small cohort of 127 patients who had undergone elective colorectal cancer surgery used the Clavien-Dindo classification of postoperative complications and reported that the severity of a complication increased with the magnitude of the postoperative day 3 CRP [7].
The aim of the present study was to examine the relationship between the established postoperative serum CRP and albumin thresholds for the development of infective complications and the severity of complications as defined by the Clavien-Dindo classification following elective surgery for colorectal cancer.
Patients and methods
Patients
This observational study included patients who underwent elective, potentially curative resection for histologically confirmed colorectal cancer in two hospitals between January 2011 and January 2013. Patients who underwent emergency surgery, who received neoadjuvant chemotherapy or radiotherapy or who had existing inflammatory conditions, e.g. inflammatory bowel disease and the systemic vasculitides, were excluded.
All patients received prophylactic antibiotics and venous thromboprophylaxis prior to the induction of anaesthesia as per hospital policy. On each postoperative day, patients were clinically assessed and had blood samples, including serum CRP and albumin, obtained as standard until discharged. Further postoperative investigation and intervention was at the discretion of the patient’s surgical team who were not blind to serum CRP or albumin results.
Methods
All data was collected prospectively in a database, anonymised and was subsequently analysed. Recorded information included patient demographics, tumour site, TNM Classification of Malignant Tumours (TNM) stage (AJCC), surgical approach, complications and preoperative and postoperative serum CRP measurements. Data regarding the nature, severity and management of complications was retrospectively categorised using the Clavien-Dindo scale. Any uncertainties were addressed by review of electronic and/or physical case notes. This study was approved as part of surgical audit.
Serum concentrations of CRP (mg/L) were measured using an autoanalyzer (Architect; Abbot Diagnostics, Maidenhead, UK) with a lower detectable limit of 0.2 mg/L as was serum albumin (normal range 35–50 g/L).
The validated Clavien-Dindo classification [8], rather than defining the complication itself assigns a value from 0 (no complication) to 5 (death) based on the intervention required to treat the complication (Table 1).
The preoperative modified Glasgow Prognostic Score (mGPS), which is associated with cancer-specific survival independent of disease stage [9], was calculated in patients for whom preoperative serum CRP and albumin were available.
The neutrophil lymphocyte ratio (NLR), which is associated with cancer-specific survival independent of disease stage [10], was also calculated for each patient for whom preoperative neutrophil and lymphocyte counts were available.
Statistical analysis
Categorical data regarding patient characteristics were compared using the chi-squared test. Data regarding postoperative CRP were non-normally distributed and are presented as medians and ranges. Medians of multiple groups were compared using the Kruskal-Wallis test. The magnitude of CRP by each postoperative day was displayed as 95 % confidence intervals of the median. In all tests, a two-sided p value <0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS version 21 for Windows (Chicago, IL, USA).
Results
In total, 241 patients were included in the study. One hundred forty-two (59 %) were male, and 166 (69 %) were over 65 years old. Most had colonic (86 %) and node negative (65 %) disease. Eleven patients (5 %) had metastatic disease at the time of surgery, of whom seven had synchronous hepatectomy to treat liver metastases. The remaining four were referred to other specialities for curative surgical management of their metastatic disease following their colorectal surgery. One hundred twelve (46 %) patients had laparoscopic surgery with a further 11 (5 %) having an initial laparoscopic approach but requiring conversion to open surgery.
Of the 241 patients, a complication occurred in 119 (49 %) as shown in Table 2. The majority of complications required minimal postoperative intervention and fell into Clavien-Dindo grades 1 (22, 9 %) and 2 (69, 28 %). Complications in fewer patients required more significant action with Clavien-Dindo grade 3 representing surgical or radiological intervention (15, 6 %) and 4 of critical care requirement or organ failure (6, 3 %). Death (Clavien-Dindo grade 5) occurred in seven patients (3 %). Of the 119 complications, 94 (79 %) were due to either surgical site (65) or remote site (29) infection and the remaining 25 (21 %) were non-infective complications.
The relationship between the severity of complication and the perioperative serial CRP is shown in Fig. 1. In both cases, there was little difference in the median preoperative and first postoperative day CRP. Those who developed a complication then sustained a higher median CRP from postoperative day 2 onward.
Table 3 shows patients’ perioperative characteristics when grouped by Clavien-Dindo grade 0 (no complication), grade 1 to 2 and 3 to 5 complications. No significant difference was found in age group, gender, TNM stage or tumour site. A significantly higher proportion of patients who suffered a Clavien-Dindo grade 3 to 5 complication underwent open surgery (16 %) compared to those who underwent laparoscopic surgery (7 %, p = 0.001). A significantly greater proportion of patients who suffered a Clavien-Dindo grade 3 to 5 complication had an mGPS score of 2 (44 %) than those who experienced a grade 1 to 2 (19 %) or no complication (17 %, p = 0.02). Preoperative NLR was not significantly associated with the different Clavien-Dindo classification groups.
When compared between Clavien-Dindo grade groups 0, 1 to 2 and 3 to 5 (Table 3), there was a significant difference in median CRP on postoperative day 2 (123 vs. 176 vs. 234 mg/L, p < 0.001), day 3 (118 vs. 208 vs. 251 mg/L, p < 0.001) and day 4 (98 vs. 161 vs. 243 mg/L, p < 0.001). When compared between Clavien-Dindo grade groups 0, 1 to 2 and 3 to 5, the established postoperative day 2 CRP threshold of 190 mg/L was exceeded by 19, 44 and 61 %, respectively, (p < 0.001). When compared between Clavien-Dindo grade groups 0, 1 to 2 and 3 to 5, the established postoperative day 3 CRP threshold of 170 mg/L was exceeded by 26, 64 and 81 %, respectively, (p < 0.001). When compared between Clavien-Dindo grade groups 0, 1 to 2 and 3 to 5, the established postoperative day 4 CRP threshold of 125 mg/L was exceeded by 42, 64 and 86 %, respectively, (p < 0.001).
When compared between Clavien-Dindo grade groups 0, 1 to 2 and 3 to 5 (Table 3), there was a significant difference in median albumin on postoperative day 2 (28 vs. 27 vs. 24 g/L, p < 0.001), day 3 (28 vs. 26 vs. 23 g/L, p < 0.001) and day 4 (27 vs. 25 vs. 23 g/L, p < 0.001). When compared between Clavien-Dindo grade groups 0, 1 to 2 and 3 to 5, the established postoperative day 3 albumin threshold of 25 g/L was breached by 23, 48 and 64 %, respectively (p < 0.001).
Discussion
The results of the present study demonstrate that established postoperative serum CRP and albumin thresholds as measured on days 2, 3 and 4 following elective surgery for colorectal cancer can not only be used to predict the type but also the severity of postoperative complications, as defined by the Clavien-Dindo scale. In particular, those patients who required significant surgical or radiological intervention, ITU admission or who died (grades 3 to 5) exceeded those thresholds previously defined for the development of infective complications.
In the present study, the proportions of patients in Clavien-Dindo grades 1 to 5 were similar (49 %) to those in Selby and colleague’s paper (43 %) as were the proportions in grades 3 to 5 at 12 and 11 %, respectively[7], although the present study had almost double the number of patients. Similarly, Selby and coworkers included only elective operations for colorectal cancer; however, it was not clear whether they included patients who had undergone neoadjuvant treatment nor was there data regarding the site of tumours or whether patients underwent laparoscopic surgery.
In the present study, approximately half of the patients underwent laparoscopic surgery. It was of interest that fewer patients who underwent laparoscopic surgery developed Clavien-Dindo grade 3 to 5 complications when compared to open surgery. Given that laparoscopic surgery is recognised to generate a smaller systemic inflammatory response than open surgery [11–13], the present results would suggest that there is a causal relationship between the magnitude of the surgical trauma and the severity of complications following surgery for colorectal cancer. Further work investigating the relationship between the magnitude of the postoperative systemic inflammatory response and the severity of complications in patients undergoing surgery for colorectal cancer is warranted.
The use of the postoperative systemic inflammatory response as evidenced by CRP measurement in colorectal cancer surgery to detect infectious complications has been applied successfully to other cancer surgery [14–16] and to surgery for benign conditions [17]. It may be that the findings of the present study can also be applied to surgery for other cancers and benign disease. If so, the implications for surgery are profound, providing for the first time an objective postoperative therapeutic target. Moreover, complications of increasing severity may also lead to poorer long-term outcomes, although only a small number of studies have examined this in the context of the Clavien-Dindo classification [18]. It remains to be determined whether strategies to reduce the magnitude of the systemic inflammatory response in the perioperative period will also reduce the severity of postoperative complications.
The main limitation of the present study was the relatively small number of patients examined, particularly with regard to those with Clavien-Dindo grade 3 to 5 complications, although the proportion of patients in each grade was similar to that in Selby and colleague’s report in 127 patients [7]. Using the Clavien-Dindo system may lead to some bias as surgeons, anaesthetists and ward staff may manage a given case or complication differently from one another. The surgical teams caring for each patient were not blind to the postoperative CRP or albumin concentration as it was used as a part of routine clinical care and may have guided, in part, the patient management on which the Clavien-Dindo definitions depend. The present work requires external validation.
In summary, there was a direct association between the postoperative systemic inflammatory response, as evidenced by serum CRP and albumin, and the severity of complications following surgery in patients with colorectal cancer.
References
Cancer Stats, Cancer Research UK. (2014) http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers/. Accessed 19 Jan 2015
Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P (2011) Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 253:890–899
Warschkow R, Beutner U, Steffen T, Muller SA, Schmied BM, Guller U, Tarantino I (2012) Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients. Ann Surg 256:245–250
Singh PP, Zeng ISL, Srinivasa S, Lemanu DP, Connolly AB, Hill AG (2014) Systematic review and meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after colorectal surgery. Br J Surg 101:339–346
Platt JJ, Ramanathan ML, Crosbie RA, Anderson JH, McKee RF, Horgan PG, McMillan DC (2012) C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol 19:4168–4177
Dindo D, Demartines N, Clavien P (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Selby J, Prabhudesai A (2014) Can C-reactive protein predict the severity of a post-operative complication after elective resection of colorectal cancer. Int J Colorectal Dis 29(10):1211–1215
Clavien P, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Padbury R, Vonlanthen R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five year experience. Ann Surg 250:187196
McMillan DC (2012) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 36:534–540
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218–230
Wichmann MW, Huttl TP, Winter H, Spelsberg F, Angele MK, Heiss MM, Jauch KW (2005) Immunological effects of laparoscopic vs open colorectal surgery: a prospective clinical study. Arch Surg 140:692–697
Ortega-Deballon P, Radais F, Facy O, d’Athis P, Masson D, Charles PE, Cheynel N, Favre JP, Rat P (2010) C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg 34:808–814
Ramanathan ML, MacKay G, Platt J, Horgan PG, McMillan DC (2014) The impact of open versus laparoscopic resection for colon cancer on c-reactive protein concentrations as a predictor of postoperative infective complications. Ann Surg Oncol. doi:10.1245/s10434-014-4065-z
Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC (2011) Persistent elevation of c-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg 35:1017–1025
Warschkow R, Ukegjini K, Tarantino I, Steffen T, Muller SA, Schmied BM, Marti L (2012) Diagnostic study and meta-analysis of c-reactive protein as a predictor of postoperative inflammatory complications after pancreatic surgery. J Hepatobiliary Pancreat Sci 19:492–500
Warschkow R, Tarantino I, Ukegjini K, Beutner U, Muller SA, Schmied BM, Steffen T (2012) Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery. Langenbecks Arch Surg 397:727–736
Warschkow R, Tarantino I, Folie P, Beutner U, Schmied BM, Bisang P, Schultes B, Thurnheer M (2012) C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg 16:1128–1135
Pucher PH, Aggarwal R, Qurashi M, Darzi A (2014) Meta-analysis of the effect of postoperative in-hospital morbidity on long-term patient survival. Br J Surg. doi:10.1002/bjs.9615
Acknowledgments
The authors gratefully acknowledge the help and support of the consultant colorectal surgeons at Glasgow Royal Infirmary and Gartnavel General Hospital, Glasgow.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McSorley, S.T., Ramanathan, M.L., Horgan, P.G. et al. Postoperative C-reactive protein measurement predicts the severity of complications following surgery for colorectal cancer. Int J Colorectal Dis 30, 913–917 (2015). https://doi.org/10.1007/s00384-015-2229-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-015-2229-3